Is Xenon Pharmaceuticals a Good Stock to Buy Now?
Shares of Xenon Pharmaceuticals (NASDAQ: XENE), a biopharmaceutical company developing neurology drugs, shot up on Monday. Better-than-expected trial results for a potential new epilepsy treatment that has blockbuster potential written all over it did the trick.
Buying stocks just because they're going up isn't a great strategy, but you're right to wonder if this one can climb higher. Before diving in, let's see why everyone's talking about this small-cap biotech right now.
Image source: Getty Images.
Source Fool.com
